<DOC>
	<DOC>NCT01359605</DOC>
	<brief_summary>The purpose of the study is to characterize the metabolism and excretion (ADME) of a single oral dose of [14C]varespladib methyl.</brief_summary>
	<brief_title>Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Varespladib methyl</mesh_term>
	<criteria>Provision of signed, written and dated informed consent prior to any study specific procedure Healthy males, 19 to 55 years of age Have a body mass index (BMI) between 18 and 35 kg/m2 inclusive History or presence of any clinically significant disease or disorder in the opinion of the investigator Any clinically relevant abnormal findings in physical examination, clinical chemistry, haematology, urinalysis, or vital signs at baseline in the opinion of the investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>ADME</keyword>
	<keyword>Healthy volunteers</keyword>
</DOC>